In response to calls to reduce the number of experiments with non-human primates (NHP) by up to 40% in the Netherlands the Dutch Parliament has now reached a compromise.
In two motions, the parliament acknowledged the importance of animal research (including NHP) for scientific and medical progress and has stated that the 40% reduction should relate to commercial research, a goal supported by the Biomedical Primate Research Center, which has been the focus of these controversial proposals.
In addition, responding to calls that NHP research should be centralised in the Netherlands, the Parliament said that this should only be done if the facilities agreed to the proposal themselves.
EARA Executive Director, Kirk Leech, said: “It is good to see that the Dutch Parliament has recognised the value of primate research in the country and is working with the sector to adopt proposals that are workable”
EARA has responded to a call by the Dutch Science Minister for the Biomedical Primate Research Centre (BPRC), in the Netherlands, an EARA member, to draw up a proposal, by the beginning of next year, to reduce the number of experiments with no-human primates (NHP) by up to 40%.
Ahead of a debate, which took place in the Netherlands House of Representatives earlier this month, EARA wrote to Ingrid van Engelshoven, Minister of Education, Culture and Science and Carola Schouten, Minister of Agriculture, Nature and Food Quality, urging them not to set an artificial limit on the number of NHP used in research.
The letter, written by EARA, said that any reduction was “highly likely to severely limit the progress that can be made in both fundamental research and the development of innovative medicines and treatments for life-threatening diseases and infectious disease control”.
Currently the main areas of primate study are infectious diseases, neuroscience and fertility and foetal research. Primates are an important model for the development of vaccines and treatments for HIV/AIDS, Ebola, Zika and malaria and for investigations into treatments for conditions ranging from Alzheimer’s disease to Schizophrenia. They are also used in safety testing for new medicines and vaccines. Continue reading
Last week, the Dutch Parliament passed a motion supported by all parties asking Government to investigate completely phasing out non-human primate research at the Biomedical Primate Research Centre (BPRC) and other research centres. Continue reading